The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium

Sep 15, 2022

CERRITOS, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, will participate on the “Next Frontier - Value Based Care for Sub-Capitation/Specialties” panel at the Nephron 2nd Annual Physician Enablement Symposium on Thursday, September 22 at 9:00am EST.

About The Oncology Institute, Inc.

Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.7 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 90+ employed clinicians and more than 700 teammates in over 50 clinic locations and growing, TOI is changing oncology for the better. For more information visit



The Oncology Institute
Julie Korinke
(562) 735-3226 x 88806

Michael Petrone
(615) 760-4542


Solebury Trout
Maria Lycouris